We’re excited to announce that Genezen will be exhibiting at the upcoming American Society of Gene & Cell Therapy (ASGCT) annual meeting in Los Angeles. This highly anticipated event is set to take place from May 16-20, 2023, and will bring together leading experts in the field of gene therapy from around the world to discuss the latest advances and breakthroughs.

As an exhibitor, we’ll have the opportunity to showcase our cutting-edge technologies and innovative approach to viral vector manufacturing. Be sure to visit us at booth #641 to learn more about Genezen and our groundbreaking research. We’re eager to connect with fellow industry professionals and advance the field of gene therapy together.

We’re also proud to announce that we’ll be presenting at ASGCT. Our poster presentation will showcase the results of our evaluation of novel technologies for lentiviral physical titer determination, as part of our ongoing commitment to investing in cutting-edge technologies and accelerating our customers’ speed to market. We can’t wait to share our findings with the wider gene and cell therapy community and look forward to meeting many of our customers in person at ASGCT. Join us for Poster #981 on Thursday 5/18 at 12:00 pm.

Don’t miss the chance to learn more about our services and expertise at ASGCT. We look forward to seeing you there!